Introduction
Safety is an essential principle of patient care; therefore, the Fifty-fifth World Health Assembly underlined the importance of promoting science-based systems to improve patient safety and the quality of health care, including the safe use of medicinal products. 1 Medication errors and adverse drug reactions not only have an impact on human health but, are also a significant financial burden on the health care system. 2, 3 The high costs due to these events show the necessity of prevention, e.g. through educational programmes, to save money and to improve the quality of care. 2, 3 Dietary supplements, which are frequently regarded as harmless and safe by the patients, can be associated with adverse events, too. 4, 5 Deficiencies in system design, organisation and operation are primarily seen as the reasons leading to adverse events, and the individual physician may only contribute to a lesser extent. 6 As the average length of consultation in a German general practitioner's office is less than 8 minutes, the limited time with the doctor could be one aspect inherent to the health care system. 7, 8 Misinterpretation of the advice given by the physician or pharmacist, or insufficient provision of required information about the medication, may result in decreased compliance of the patient. 9 However, patient education and counselling are of prime importance to improve compliance, as a well-informed patient is the key to ensure taking the drugs prescribed. 10 In particular those patients with multiple drugs have the need for adequate information, as they are more likely to be noncompliant. 11 As one resource, patients try to inform themselves about their medication and diseases using the internet, 12 but the quality of websites about drugs and health-related topics varies widely, 13 and not authentificated information might be associated with some dangers. 14 The patient package insert of a drug could be another -and reliable -source of information. Literature data, however, suggest that patients do not understand its meaning, and that personal recommendations of a physician or pharmacist are more helpful and better accepted. 15 This is in accordance with identified preferences of patients for a patient-centred consultation including communication. 16 Drug information services managed by health care professionals can be a helpful tool to answer medication-related questions and to provide general information about drugs. 17 Such centres addressing physicians and pharmacists have existed in Germany for a long time, and their usefulness has been demonstrated. 18, 19 In 2001, a drug information service was established in Dresden, Germany, available exclusively for patients. 20, 21 For the present paper we evaluated all enquiries to this service within 6 years. The objectives were to analyse the type of enquiries as well as answers provided by the drug information service. Finally, the kind of information need on the patient side should be identified.
Methods
The drug information service for patients (DISP) -located at Organization, Geneva, Switzerland). Furthermore, the reasons for an enquiry were recorded.
These were classified into appropriate categories, e.g. adverse drug reactions, drug interactions, information about therapy, application or dosage of the drug). Statistical comparison of categorical variables was performed using chi-square test.
Continuous variables were compared with t-test and Mann-Whitney U-test. For all tests a two-sided p-value below 0.05 was considered significant. All statistical analyses were performed using SPSS 15.0.1 (SPSS Inc., Chicago, IL, USA).
Results

Patient characteristics
During the analysed period (August 2001 to January 2007), a total of 5587 enquiries were registered. Figure 1 shows the monthly number of all enquiries, which varied widely over time; on average, there were 85 enquiries per month. Restricting analysis to those enquiries for which age and gender of the patient were known, 5013 enquiries of 4091 individuals were available for further evaluation. 35.5% (n = 1451) of the patients were male, 64.5% (n = 2640) female, the mean age was 61.5 (SD 14.9) years (men: 62.5 (SD 15.0), women: 60.9
(SD 14.8); p = 0.002). The majority of patients were older than 60 (n = 2621, 64.1%). The largest group were women between 61 and 70 years (n = 955, 23.3% of patients). A higher proportion of female individuals could be found in each age group. Two thirds of the patients originated from Saxony, the geographical area around Dresden (men: 66.9%, n = 970;
women: 69.9%, n = 1845). In 85.2% (n = 4272) of the enquiries, patients contacted the DISP by themselves, whereas 14.8% (n = 741) of the enquiries were managed via a third person (e.g. spouse, child of the patient).
In 4914 enquiries, drugs were indicated by the patients. On average, men took significantly more drugs than women (5.5 (SD 3.6) vs. 4.9 (SD 3.3); p < 0.001), patients older than 60 years significantly more than patients less than or equal to 60 years of age (5.8 (SD 3.5) vs.
3.9 (SD 2.9); p < 0.001). Existing diseases of the patients were reported in 4849 enquiries. No significant difference concerning mean number of diseases was found between male and female (3.0 (SD 1.9) vs. 2.9 (SD 1.7); p = 0.388). However, the age had an impact (>60 years:
3.2 (SD 1.8) vs. ≤60 years: 2.4 (SD 1.5); p < 0.001). 535 patients contacted the DISP more than once, causing 1457 (29.1%) enquiries (Table 1 ). There was no significant difference in gender distribution between single and repeat enquiries (p = 0.674). Table 2 gives an overview of the drug and disease groups that caused an enquiry. 4914 of the 5013 enquiries analysed were drug-related. Cardiovascular drugs (ATC group C) clearly dominated with 33.4% (n = 4269), followed by drugs for the nervous system (ATC group N) with 16.2% (n = 2066). Substances enquired about without ATC code included dietary supplements, homoeopathics and medical devices, and were ranked fourth (7.5%, n = 954). It is noteworthy that only a total of 7.8% (n = 1000) of all drugs asked about were bought by the patients without prescription, including 710 dietary supplements -which were ranked sixth with 5.6% if regarded as separate category.
Content of enquiries
On average, 2. In 3339 enquiries, diseases were stated by the patients as responsible for the question to the DISP ( Table 2) . Diseases of the circulatory system (19.5%, n = 702) most frequently caused an enquiry.
Common reasons leading patients to contact the DISP were, as presented in Table 3 , adverse drug reactions (22.1%, n = 2177), the need for general information about the drug (19.9%, n = 1964), information about therapy (12.4%, n = 1221) and drug interactions (10.2%, n = 1002).
On average, there were 2.0 reasons for an enquiry of a patient. As additional cause, lack of available time of the attending physician was stated in 238 enquiries. Furthermore, each drug asked about was linked with the reasons for the question. Drugs for the blood and blood forming organs as well as for the cardiovascular system were more likely to be associated with enquiries about adverse drug reactions (25.4% and 25.9%, respectively) and drug interactions (19.8% and 18.0%, respectively). The 99 enquiries in which no drug was mentioned by the patients were mainly related to questions about treatment options in general. Table 4 shows the types of answer which were given by the DISP during consultations. As the answers provided were dealing with the individual problems of the patients in a more detailed way, the totalled number was higher than the number of reasons leading to an enquiry.
Type of information provided by the DISP
General information about the drug was most frequently given as answer (24.4%, n = 3000).
Advice concerning adverse drug reactions was in the second place, accounting for 14.8% (n = 1827). In 1453 consultations patients were encouraged to visit a physician for discussing their drug-related problem. The average time to answer an enquiry (investigation and counselling the patient) was 26.7 (SD 17.5) minutes (data were not available for 187 enquiries).
Discussion
In the analysed period, the DISP was frequently contacted by patients, indicating an existing need for additional information about their medication. There was a wide fluctuation in the monthly number of enquiries to the service over time. Advertising in print media as well as via radio or television highly increased the number of questions.
The majority of enquiring patients were older than 60 years. As the number of drugs prescribed increases with age, 25, 26 and polypharmacy is associated with a higher risk for several health problems (e.g. adverse drug reactions), 27 a greater need for medication-related information among the elderly may have been the underlying reason. In addition, more women than men used the DISP, possibly due to their higher proportion in the older population. 28 As this, however, does not explain the imbalance between male and female among younger patients, another factor could have been that women are more likely to use external help than men. 29 Reports on drug information services in other countries showed a gender distribution comparable to our findings. 30, 31, 32 As expected, patients contacting the service more than once were older, had to take more drugs or were suffering from more diseases, which increased the number of medication-related questions. On average, men asked about significantly more drugs per enquiry than women, correlating with a larger number of drugs taken. Their higher mean age may have been responsible, because older age is generally associated with an increased medication use. 25, 26 In addition, the number of drugs prescribed to older men slightly exceeds that prescribed to older women. 26 The distribution of the drug groups enquired about was paralleled by national prescription figures, for the year 2006 see Table 5 , with few exceptions (e.g. antibacterials for systemic use/ATC group J01). 33 Drugs for the cardiovascular system were most commonly prescribed in the analysed period, 33, 34 and they were most often stated by the patients as reason for an enquiry -more frequently by older as well as male individuals, which is in accordance with findings from the literature, too. 25 Moreover, as mental disorders are highly prevalent in the German population, 35 a lot of questions were about drugs for the nervous system. In general, the medication asked about correlated with the patient-reported diseases. However, as diseases of the circulatory system are usually treated with a combination of multiple agents, the proportion of cardiovascular drugs was substantially higher. The fact that the majority of questions were related to frequently prescribed drugs, and not only to those with special pharmacological characteristics, may argue for a general information need. Furthermore, the number of dietary supplements enquired about -taken by the patients without consultation of a doctor -was notable. Limited product information might lead to misconceptions about the effects of these substances. 36 Therefore, drug information centres can be useful as a valuable source of information. 37 Adverse drug reactions are common reasons for contacting a drug information service, 31, 32, 38 which was also observed in our evaluation of the DISP, and are of particular relevance for patient safety. Adverse drug reactions are responsible for an increasing number of hospital admissions in recent years. 39 Certain drugs, e.g. for the blood and blood forming organs or for the cardiovascular system, are more likely to be associated with serious adverse events. 40 As a considerable number of adverse drug reactions leading to hospitalisation is regarded as avoidable -especially in older individuals -appropriate prevention is needed. 40 Sufficient information of the patient could be one important measure.
In addition, patients who experienced adverse drug reactions are more likely to be noncompliant. 41 On the other hand, adequate consultation on the prescribed drugs and the concept of therapy leads to increased compliance. 41 For this purpose, distance medicine technology (e.g. telephone counselling as provided by the DISP) can be one useful instrument which has shown benefits for the patients. 42 Consultations by phone are highly accepted due to convenience, 43 and may reduce the use of medical care -implicating potential cost saving effects. 44 The intention of the DISP was not to substitute the face-to-face consultation with the treating physician, who knows most of the patient and his medical history, and who should be the primary responsible for providing comprehensive information about the use of medication.
However, the service was supportive whenever there were any further questions on the patients' side. As mostly self-motivated individuals are addressed by a telephone-based drug information service, further research is needed to determine how to reach other patient groups. 31 The advice provided by the DISP could only be given within the context of patients' selfreported information about their drugs and diseases. This is a limitation of an independent and telephone-based drug information service, as it was not possible to verify patients' statements with medical records kept by attending physicians. However, there is evidence from the literature that self-reports by patients are reliable when compared to objectively obtained data.
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Conclusion
The findings that emerge from our experience with a drug information service for patients demonstrate an existing need on the patient side for additional counselling about the medication. In particular frequently prescribed drugs were enquired about, which may indicate an information need not only for drugs with special pharmacological characteristics.
Medical advice given by telephone may serve as an additional source of drug-related information for patients. Therefore, the DISP can be one helpful tool to counteract information deficits and to increase patients' knowledge about their medication.
of the study sponsor in study design, in the collection, analysis and interpretation of data, in the writing of the report and in the decision to submit the report for publication.
The authors are grateful to all former and present staff members of the Institute of Clinical Pharmacology, Faculty of Medicine of the Technische Universität Dresden, Germany, involved in the drug information service.
Key points
 A lot of patients need additional information about their medication.
 The drug information service for patients can be a useful instrument to counteract deficits in drug-related knowledge.
 Enquiries were mainly related to frequently prescribed medication, such as drugs for the cardiovascular system, for the nervous system or for the alimentary tract and metabolism.
 Adverse drug reactions were the most common reason for contacting the service.
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Figure 1
Number of all enquiries to the drug information service for patients per month in the period from August 2001 to January 2007 Table 1 Differences in patient characteristics between single and repeat enquiries *Percentages may not add exactly to 100.0 due to rounding error. Table 2 Drugs and diseases that caused an enquiry, classified according to ATC system and ICD-10, ++ Based on 3339 enquiries.
Table 3
Reasons that led patients to contact the drug information service, shown for all enquiries in general, and linked with different major groups of drugs asked about (according to ATC classification system). More than one reason for an enquiry could be indicated ATC, Anatomical Therapeutic Chemical; A, alimentary tract and metabolism; B, blood and blood forming organs; C, cardiovascular system; G/H, genito urinary system and sex hormones/systemic hormonal preparations, excluding sex hormones and insulins; J/L, antiinfectives for systemic use/antineoplastic and immunomodulating agents; M, musculoskeletal system; N, nervous system. *Substances without ATC code, including dietary supplements.
**Percentages in several columns do not add exactly to 100.0 due to rounding error.
Table 4
Types of answer provided by the drug information service. More than one category per enquiry was possible *Percentages do not add exactly to 100.0 due to rounding error.
Table 5
The 12 most frequently prescribed drug groups in Germany (at the expense of the Statutory Health Insurance), 33 
